Skip to main content

Table 2 Diagnostic phase indicators

From: Multicentre clinical radiotherapy audit in rectal cancer: results of the IROCA project

INDICATORS

ICO-B

ICO-G

ICO H

IPO

NO

WCO

All

 

N

(%)

N

(%)

N

(%)

N

(%)

N

(%)

N

(%)

N

%

P

Diagnosed at a different hospital

23

(57.5)

33

(82.5)

37

(92.5)

38

(97.4)

12

(54.5)

37

(92.5)

180

81.4

0.000

Pre-treatment MRI

34

(85.0)

40

(100)

40

(100)

24

(61.5)

18

(81.8)

37

(92.5)

193

87.3

0.000

Pre-treatment pelvic US

16

(40.0)

3

(7.5)

17

(42.5)

17

(43.6)

5

(22.7)

3

(7.5)

61

27.6

0.000

Pre-treatment thoracoabdominal CT

40

(100)

40

(100)

39

(97.5)

37

(94.9)

19

(86.4)

6

(15.0)

181

81.9

0.000

TNM staging

40

(100)

39

(97.5)

40

(100)

35

(89.7)

22

(100)

39

(97.5)

215

97.3

0.046

MRI staging

36

(90)

34

(85.0)

36

(90)

4

(10.3)

0

(0.0)

38

(95.0)

148

67.0

0.000

Presented to MTB

25

(62.5)

20

(50.0)

34

(85.0)

39

(100)

11

(50.0)

38

(95.0)

167

75.6

0.000

Presented at pre-treatment RO clinical session

40

(100)

40

(100)

39

(97.5)

0

(0.0)

22

(100)

0

(0.0)

141

63.8

0.000

Time between biopsy and first visit at RO (±4) [days]

32.6

30.5

39.2

58.6

45.9

21.6

210

37.6

< 0.001

Time between first visit at RO and beginning of RT [days]

15.1

16.5

19.7

16.0

28.5

38.8

221

22.0

< 0.001